1. Dispenzieri A. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol. 2014; 89:214–223. PMID:
24532337.
Article
2. Higashi AY, Nogaki F, Kato I, Ono T, Fukatsu A. Serial renal biopsy findings in a case of POEMS syndrome with recurrent acute renal failure. Clin Exp Nephrol. 2012; 16:173–179. PMID:
21979795.
Article
3. Floege J, Johnson RJ, Feehally J. Comprehensive Clinical Nephrology. 5th ed. Expert Consult-Online: Elsevier Health Sciences;2014. p. 1000–1002.
4. Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand JP, et al. International Kidney and Monoclonal Gammopathy Research Group: Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015; 87:698–711. PMID:
25607108.
5. Ropper AH, Raje NS, Lawrimore TM, Camelo-Piragua S, Sohani AR. Case records of the Massachusetts General Hospital. Case 7-2010. A 49-year-old man with peripheral neuropathy and ascites. N Engl J Med. 2010; 362:929–940. PMID:
20220188.
6. Sanada S, Ookawara S, Karube H, Shindo T, Goto T, Nakamichi T, et al. Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation. Am J Kidney Dis. 2006; 47:672–679. PMID:
16564945.
Article
7. Dispenzieri A. How I treat POEMS syndrome. Blood. 2012; 119:5650–5658. PMID:
22547581.
Article
8. Ye W, Wang C, Cai QQ, Duan MH, Li H, Cao XX, et al. Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome. Nephrol Dial Transplant. 2016; 31:275–283. PMID:
26130736.
Article